SYK Insider Trading

Insider Ownership Percentage: 5.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $172,878,259.30

Stryker Insider Trading History Chart

This chart shows the insider buying and selling history at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$50M$0$50MTotal Insider BuyingTotal Insider Selling

Stryker Share Price & Price History

Current Price: $346.46
Price Change: Price Decrease of -0.21 (-0.06%)
As of 04/17/2025 04:59 PM ET

This chart shows the closing price history over time for SYK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$346.46Closing price on 04/17/25:

SEC Filings (Institutional Ownership Changes) for Stryker (NYSE:SYK)

77.09% of Stryker stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SYK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$817Mbought$42MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$4B-$2B$0$2B$4BTotal InflowsTotal Outflows
Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More on Stryker

Today's Range

Now: $346.46
Low: $343.19
High: $351.04

50 Day Range

MA: $371.83
Low: $336.96
High: $396.10

52 Week Range

Now: $346.46
Low: $314.93
High: $406.19

Volume

1,349,873 shs

Average Volume

1,362,954 shs

Market Capitalization

$132.24 billion

P/E Ratio

44.65

Dividend Yield

0.97%

Beta

0.93

Who are the company insiders with the largest holdings of Stryker?

Stryker's top insider investors include:
  1. Ronda E Stryker (Director)
  2. Kevin Lobo (CEO)
  3. Allan C Golston (Director)
  4. M Kathryn Fink (VP)
  5. Viju Menon (Insider)
  6. Srikant M Datar (Director)
  7. William E Berry Jr (CAO)
  8. Glenn S Boehnlein (CFO)
Learn More about top insider investors at Stryker.

Who are the major institutional investors of Stryker?

Stryker's top institutional shareholders include:
  1. GAMMA Investing LLC — 0.54%
  2. Rhumbline Advisers — 0.17%
  3. Fenimore Asset Management Inc — 0.14%
  4. Handelsbanken Fonder AB — 0.07%
  5. Confluence Investment Management LLC — 0.06%
  6. Chicago Capital LLC — 0.05%
Learn More about top institutional investors of Stryker stock.

Which institutional investors are selling Stryker stock?

In the last quarter, SYK stock was sold by these institutional investors:
  1. Nixon Peabody Trust Co.
  2. Dividend Assets Capital LLC
  3. Mn Services Vermogensbeheer B.V.
  4. Confluence Investment Management LLC
  5. First Financial Bank Trust Division
  6. Greenwood Capital Associates LLC
  7. Avanza Fonder AB
  8. Wendell David Associates Inc.
During the previous year, company insiders that have sold Stryker company stock include:
  1. Ronda E Stryker (Director)
  2. Kevin Lobo (CEO)
  3. Allan C Golston (Director)
  4. M Kathryn Fink (VP)
  5. Viju Menon (Insider)
  6. Srikant M Datar (Director)
Learn More investors selling Stryker stock.

Which institutional investors are buying Stryker stock?

Within the previous quarter, SYK stock was purchased by institutional investors including:
  1. GAMMA Investing LLC
  2. Bank Pictet & Cie Europe AG
  3. 626 Financial LLC
  4. Smithbridge Asset Management Inc. DE
  5. Handelsbanken Fonder AB
  6. NBC Securities Inc.
  7. Rhumbline Advisers
  8. Fifth Third Bancorp